Robert Cascella has bought stock on 6 days since Aug 2021

Robert A. Cascella is a corporate insider and seasoned healthcare executive currently serving as Chairman of the Board of Directors at Neuronetics, Inc. (NASDAQ: STIM), where he has been a director since April 2021.( He brings more than three decades of leadership experience in medical technology and diagnostics, and has played a key role in guiding Neuronetics’ strategy and governance while overseeing board leadership transitions, including his appointment as chairman following the retirement of Brian Farley in 2021.(

Prior to Neuronetics, Cascella held senior roles at Royal Philips N.V., where he joined in 2015 and led global businesses in diagnosis and treatment.( Earlier, he spent 11 years at Hologic, Inc., serving first as President and later as Chief Executive Officer, helping to build the company into a leading medical imaging and women’s health enterprise.( He currently serves on multiple public and private company boards, including Celestica (NYSE: CLS), Koru Medical Technologies (NASDAQ: KRMD), Metabolon, and Mirion Technologies (NYSE: MIR), reflecting his broad influence across the medical technology and industrial sectors.( Cascella holds a Bachelor of Arts in Accounting from Fairfield University, providing the financial and strategic foundation for his long-standing career in healthcare leadership and corporate governance.(

Written by Perplexity from public sources.